Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wingerson

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Biological Psychiatry|July 1, 1996
Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and genderE R Peskind, M A Raskind, D Wingerson, et al.
Biological Psychiatry|September 15, 1996
Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panicD S Cowley, J B Adams, R E Pyke, et al.
Biological Psychiatry|October 15, 1995
Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasmaE R Peskind, D Wingerson, M Pascualy, et al.
Psychoneuroendocrinology|January 1, 1995
Lack of cholinergic regulation of vasopressin and norepinephrine responses to hypertonic saline in humansM Pascualy, E R Peskind, D Wingerson, et al.
Archives of General Psychiatry|September 1, 1995
Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidineE R Peskind, D Wingerson, S Murray, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 1, 1995
Enhanced hypothalamic-pituitary-adrenocortical axis responses to physostigmine in normal agingE R Peskind, M A Raskind, D Wingerson, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Biological Psychiatry|July 1, 1996
Hypothalamic-pituitary-adrenocortical axis responses to physostigmine: effects of Alzheimer's disease and genderE R Peskind, M A Raskind, D Wingerson, et al.
Biological Psychiatry|September 15, 1996
Effect of CI-988, a cholecystokinin-B receptor antagonist, on lactate-induced panicD S Cowley, J B Adams, R E Pyke, et al.
Biological Psychiatry|October 15, 1995
Oral physostigmine in Alzheimer's disease: effects on norepinephrine and vasopressin in cerebrospinal fluid and plasmaE R Peskind, D Wingerson, M Pascualy, et al.
Psychoneuroendocrinology|January 1, 1995
Lack of cholinergic regulation of vasopressin and norepinephrine responses to hypertonic saline in humansM Pascualy, E R Peskind, D Wingerson, et al.
Archives of General Psychiatry|September 1, 1995
Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidineE R Peskind, D Wingerson, S Murray, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 1, 1995
Enhanced hypothalamic-pituitary-adrenocortical axis responses to physostigmine in normal agingE R Peskind, M A Raskind, D Wingerson, et al.
Pageof 2